Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Barbados cherry (Malpighia emarginata) contains phenolic compounds, particularly in its acetone and hexane fractions. These compounds demonstrate tumor-specific cytotoxicity against various cancer cells and effectively reverse multidrug resistance.
Reported Benefits (Provisional)
Origin & History
A vibrant fruit (Malpighia emarginata), often referred to as Acerola or West Indian Cherry, native to the Caribbean, particularly Cuba and the Dominican Republic. It thrives in tropical and subtropical climates, valued for its exceptional antioxidant profile and immune-boosting properties.
Research Narrative (Provisional)
Scientific research extensively documents the potent antioxidant and anti-inflammatory properties of Cuban Bastard Cherry, particularly its high vitamin C and polyphenol content. Studies investigate its cardiovascular and neuroprotective benefits, alongside its immune-enhancing and gut-supporting effects, validating its traditional uses.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Phytochemicals: Anthocyanins, flavonoids (quercetin, kaempferol), polyphenols (ellagic acid, catechins), carotenoids (beta-carotene, lutein), tannins, saponins. - Vitamins: Vitamins A, C, E. - Minerals: Magnesium, potassium, calcium. - Macronutrients: Prebiotic fibers.
Reported Mechanism (Provisional)
Barbados cherry extracts exert their primary anticancer mechanism through specific phenolic compounds found in acetone and hexane fractions. These compounds induce tumor-specific cytotoxicity, selectively targeting and eliminating various cancer cell lines, such as human oral squamous cell carcinoma, while sparing normal cells. Furthermore, these fractions demonstrate a potent ability to reverse multidrug resistance in cancer cells, potentially enhancing the efficacy of conventional treatments.
Clinical Narrative (Provisional)
Current scientific understanding regarding Barbados cherry's cytotoxic and multidrug resistance-reversing properties primarily stems from in vitro studies. These preclinical investigations, utilizing human cancer cell lines like HSC-2 and HSG, have demonstrated the selective toxicity of phenolic fractions against malignant cells while preserving normal human fibroblasts. However, human clinical trials assessing these specific anticancer effects, including dosage, efficacy, and safety in various populations, are currently lacking. Further research is needed to translate these promising laboratory findings into clinical applications.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.